Visual assessment of biliary excretion of Gd-EOB-DTPA in patients with suspected diffuse liver disease – A biopsy-verified prospective study

نویسندگان

  • Bengt Norén
  • Nils Dahlström
  • Mikael Fredrik Forsgren
  • Olof Dahlqvist Leinhard
  • Stergios Kechagias
  • Sven Almer
  • Staffan Wirell
  • Örjan Smedby
  • Peter Lundberg
چکیده

OBJECTIVES To qualitatively evaluate late dynamic contrast phases, 10, 20 and 30 min, after administration of Gd-EOB-DTPA with regard to biliary excretion in patients presenting with elevated liver enzymes without clinical signs of cirrhosis or hepatic decompensation and to compare the visual assessment of contrast agent excretion with histo-pathological fibrosis stage, contrast uptake parameters and blood tests. METHODS 29 patients were prospectively examined using 1.5 T MRI. The visually assessed presence or absence of contrast agent for each of five anatomical regions in randomly reviewed time-series was summarized on a four grade scale for each patient. The scores, including a total visual score, were related to the histo-pathological findings, the quantitative contrast agent uptake parameters, expressed as K Hep or LSC_N, and blood tests. RESULTS No relationship between the fibrosis grade or contrast uptake parameters could be established. A negative correlation between the visual assessment and alkaline phosphatase (ALP) was found. Comparing a sub-group of cholestatic patients with fibrosis score and Gd-EOB-DTPA dynamic parameters did not add any additional significant correlation. CONCLUSIONS No correlation between visually assessed biliary excretion of Gd-EOB-DTPA and histo-pathological or contrast uptake parameters was found. A negative correlation between the visual assessment and alkaline phosphatase (ALP) was found.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Primovist, Eovist: what to expect?

Gadolinium ethoxybenzyl dimeglumine (Gd-EOB-DTPA, Primovist in Europe and Eovist in the USA) is a liver-specific magnetic resonance imaging contrast agent that has up to 50% hepatobiliary excretion in the normal liver. After intravenous injection, Gd-EOB-DTPA distributes into the vascular and extravascular spaces during the arterial, portal venous and late dynamic phases, and progressively into...

متن کامل

Accumulation of Bile in the Gallbladder: Evaluation by means of Serial Dynamic Contrast-Enhanced Magnetic Resonance Cholangiography with Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid

The aim of this study was to evaluate the process of biliary excretion of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) into the biliary tract and to assess the accumulation patterns in the gallbladder using MR cholangiography obtained with Gd-EOB-DTPA which is a liver-specific hepatobiliary contrast agent. Seventy-five patients underwent Gd-EOB-DTPA enhanced MR imagi...

متن کامل

Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.

PURPOSE To evaluate the biliary enhancement dynamics of the two gadolinium chelates Gd-BOPTA (MultiHance) and Gd-EOB-DTPA (Primovist) in normal healthy subjects. MATERIAL AND METHODS Ten healthy volunteers were evaluated with both agents by magnetic resonance (MR) imaging at 1.5T using a breath-hold gradient-echo T1-weighted VIBE sequence. The relative signal intensity (SI) differences betwee...

متن کامل

MR Cholangiography with Gd-EOB-DTPA: Biliary Enhancement Dynamics in Clinical Patients

Purpose: Gd-EOB-DTPA is a liver-specific MR imaging contrast agent that is taken up by hepatocytes and excreted into the biliary system. MR cholangiography can be obtained by means of three-dimensional T1-weighted imaging at the optimal scan delay after the injection of Gd-EOB-DTPA (1). The aim of the present study was to evaluate the biliary enhancement dynamics of Gd-EOB-DTPA at MR cholangiog...

متن کامل

Gd-EOB-DTPA (EovistO), A Liver Specific Contrast Agent For MRI: Results of a Placebo Controlled, Double Blind Dose Ranging Study in Patients with Focal Hepatic Lesions

The objective of this study was to determine the diagnostic efficacy and safety of Gd-EOB-DTPA (Eovista) at 4 doses (3.0; 6.0; 12.5 and 25 pmol Gd-EOB-DTPNkg BW [body weight]) as compared to placebo (0.9% salinc) in patients with known focal liver lesion(s) A total of 171 received contrast medium injection or placebo (0.9% salinc) Thirty five patients received placebo, 33 patients receivcd 3, 3...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 2  شماره 

صفحات  -

تاریخ انتشار 2015